Pfizer’s ABRYSVO Shows Promise as RSV Vaccine for At-Risk Adults: Phase 3 Study Results By bigbreakingwire on 09/04/2024
Pfizer’s Plan to Sold Roughly 630 Million Haleon Shares in Consumer Healthcare Shift Pfizer’s Plan to Sold Roughly 630 Million Haleon Shares in Consumer Healthcare Shift By bigbreakingwire on 18/03/2024
